HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Health Subcommittee Chair Prioritizes Affordability, Innovation, Ending COVID PHE

Executive Summary

Kentucky Republican Brett Guthrie is strong proponent of health care affordability and innovation in pharmaceuticals and medical devices. He’s also monitoring FDA’s response to drug shortages and infant formula shortages.

You may also be interested in...



Democrat, Republican Pioneer Women In US House Won’t Return After 2024 Elections

Granger’s exit means House Appropriations will have different chair no matter which party wins majority 2024 elections; Democrats will lose senior House Energy and Commerce Health Subcommittee member with Eshoo’s retirement.

House Energy And Commerce Lists Infant Formula Crisis First In Stating FDA Oversight Priorities

Infant formula supply shortage affecting US since early 2022 is first among multiple FDA concerns Energy and Commerce GOP leadership stated in plan submitted to Oversight and Rules Committee, as required in a standing House rule.

Rodgers Takes House Energy And Commerce Helm Criticizing ‘Administration Gone Woke’

Day after taking chair of committee with FDA oversight, Rodgers criticizes White House’s declaration extending COVID-19 public health emergency. House Appropriation chair Granger prioritizes cutting spending, boosting military.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153318

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel